GlassScriptPhysician profile
Kenneth Henry Copperwheat
NPI 1316393879
$9,053.86
in general payments reported to CMS, 2019-2025
23 companies · $4,742 in 2025
The $4,742 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,746 · 2022: $1,190 · 2023: $1,228 · 2024: $147 · 2025: $4,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,313 · Education: $2,000 · Food and Beverage: $1,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,312.72 |
| Education | $2,000.00 |
| Food and Beverage | $1,805.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,480.97 | 2021-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $1,358.43 | 2025 | Apollo Esg Nxt System, Overstitch Endoscopic Suturing System, Overstitch Nxt Endoscopic Suturing System |
| Stryker Corporation | $645.89 | 2022 | |
| Novo Nordisk INC | $301.77 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Medtronic, INC. | $285.00 | 2022 | |
| Endogastric Solutions, INC | $141.21 | 2023 | Esophyx |
| W. L. Gore & Associates, INC. | $137.99 | 2021 | |
| Lilly USA, LLC | $130.85 | 2024-2025 | Zepbound |
| Lucid Diagnostics INC. | $113.13 | 2022-2023 | |
| Tela Bio, INC. | $73.50 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ambu INC. | $53.64 | 2022 | |
| Abbvie INC. | $49.96 | 2022 | |
| Davol INC. | $48.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.61 | 2024 | Gattex |
| Apollo Endosurgery US INC | $32.43 | 2023 | Overstitch Endoscopic Suturing System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $28.27 | 2022-2025 | Aponvie |
| Ethicon US, LLC | $26.24 | 2025 | Vistaseal, Surgicel Nu-Knit, Stratafix |
| Vertex Pharmaceuticals Incorporated | $21.21 | 2025 | |
| Integra Lifesciences Corporation | $18.73 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Myriad Genetic Laboratories, INC. | $18.14 | 2021 | |
| Teleflex LLC | $16.27 | 2022 | |
| Conmed Corporation | $13.71 | 2025 | Airseal |
| Currax Pharmaceuticals LLC | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Copperwheat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.